| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-642-68006-9_12 |
| P953 | full work available at URL | https://link.springer.com/content/pdf/10.1007/978-3-642-68006-9_12 |
| P698 | PubMed publication ID | 6185454 |
| P2093 | author name string | D. R. Cox | |
| C. J. Epstein | |||
| J. Weil | |||
| L. B. Epstein | |||
| P2860 | cites work | Mouse News Letter | Q22023346 |
| The linkage of genes for the human interferon-induced antiviral protein and indophenol oxidase-B traits to chromosome G-21 | Q24679138 | ||
| Texas Reports on Biology and Medicine | Q26808291 | ||
| Chromosome 21 and the cell growth inhibitory effect of human interferon preparations | Q34656845 | ||
| Genes coding for sensitivity to interferon (IfRec) and soluble superoxide dismutase (SOD-1) are linked in mouse and man and map to mouse chromosome 16 | Q36364578 | ||
| Letter: Superoxide dismutase in Down syndrome | Q39333517 | ||
| Dosage effect of SOD-A gene in 21-trisomic cells | Q39758590 | ||
| Lymphoblastogenesis in Down's syndrome and its inhibition by human interferon | Q39863621 | ||
| Down's syndrome and acute leukemia: myeloblastic or lymphoblastic? Report of forty-three cases and review of the literature | Q39886012 | ||
| Familial hypercholesterolemia. A genetic regulatory defect in cholesterol metabolism | Q39920068 | ||
| Use of mutant fibroblasts in the analysis of the regulation of cholesterol metabolism in human cells | Q39924668 | ||
| Localization of the Gene AVG for the Antiviral Expression of Immune and Classical Interferon to the Distal Portion of the Long Arm of Chromosome 21 | Q39996635 | ||
| Systematic approach to the study of trisomy in the mouse. II | Q41532384 | ||
| Confirmation of the assignment of the human SODS gene to chromosome 21q22. | Q43579732 | ||
| Chromosome variation and gene action | Q44561363 | ||
| Synthesis of Interferon-Induced Polypeptides in Normal and Chromosome 21-Aneuploid Human Fibroblasts: Relationship to Relative Sensitivities in Antiviral Assays | Q44730845 | ||
| Effect of priming on interferon inhibition of con A induced spleen cell blastogenesis. | Q44790176 | ||
| Effect of human interferon preparations on lymphoblastogenesis in Down's syndrome | Q47965026 | ||
| Biochemical characterization of six trisomics of grain sorghum, Sorghum bicolor (L.) Moench | Q50953591 | ||
| Some thoughts on a possible relationship between known gene dosage effects and neoplastic transformation. | Q53600255 | ||
| Antibodies to a cell-surface component coded by human chromosome 21 inhibit action of interferon | Q59064916 | ||
| Regulation of chromosome 21-directed anti-viral gene(s) as a consequence of age | Q59064938 | ||
| Gene deletion as the cause of α thalassaemia: Genetic lesion in homozygous α thalassaemia (hydrops fetalis) | Q59064946 | ||
| Inhibition of interferon action by plant lectins | Q59064960 | ||
| Chromosome Redundancy and Gene Expression: an Explanation for Trisomy Abnormalities | Q59065041 | ||
| Gene dosage for isocitrate dehydrogenase in mouse embryos trisomic for chromosome 1 | Q59065045 | ||
| Dr A. S. Russell | Q59074404 | ||
| Increase in glutathione peroxidase activity in erythrocytes from trisomy 21 subjects | Q67348607 | ||
| Trisomy 21 and superoxide dismutase-1 (IPO-A). Tentative localization of sub-band 21Q22.1 | Q67432394 | ||
| Impaired in vitro response of circulating lymphocytes to phytohemagglutinin in Down's syndrome: dose- and time-response curves and relation to cellular immunity | Q68465947 | ||
| Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state | Q68699779 | ||
| Trisomy in the fetal backcross progeny of male and female metacentric heterozygotes of the mouse. i | Q68899007 | ||
| Gene dosage effect for glycinamide ribonucleotide synthetase in human fibroblasts trisomic for chromosome 21 | Q70529145 | ||
| T-lymphocyte function and sensitivity to interferon in trisomy 21 | Q72607630 | ||
| Reversible inhibition by interferon of the maturation of human peripheral blood monocytes to macrophages | Q72613391 | ||
| Enhanced sensitivity of trisomy 21 monocytes to the maturation-inhibiting effect of interferon | Q72613395 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 155-172 | |
| P577 | publication date | 1981-01-01 | |
| P1433 | published in | Human genetics. Supplement | Q27711312 |
| P1476 | title | Functional Implications of Gene Dosage Effects in Trisomy 21 | |
| P478 | volume | 2 |
| Q37615256 | Analysis of two-dimensional protein patterns from mouse embryos with different trisomies |
| Q33236637 | Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. |
| Q41547473 | Developmental pathogenesis of chromosome disorders: Report on two newly recognized signs of down syndrome |
| Q46652242 | Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome |
| Q70180242 | Interferon induction of (2??5?) oligoisoadenylate synthetase in diploid and trisomy 21 human fibroblasts: Relation to dosage of the interferon receptor gene (IRFC) |
| Q28588697 | Overexpression of liver-type phosphofructokinase (PFKL) in transgenic-PFKL mice: implication for gene dosage in trisomy 21 |
| Q41907866 | Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation |
| Q35882394 | Statistical models for trisomic phenotypes. |
Search more.